Terug naar Nieuws


LeQuest pledges to supports the international effort to battle the Corona Virus

Due to the Corona virus outbreak, it is now all hands on deck in the ICU. Many hospitals have started to prepare their respiratory OR equipment as back-up to create additional ICU capacity if needed.

However, this outbreak might require fast track training of the medical staff involved. This is a challenge, especially when trainers and the device are becoming increasingly overloaded.

In light of the corona virus pandemic, LeQuest has pledged to provide unlimited free access to our e-training for the Aisys CS2 to ensure that corona virus preparedness for any Healthcare organization in need.

We are fully committed to providing support to meet community health needs during this time. If your Hospital or Clinic has the AisysCS2 Ventilator, and you require any additional or first-time training for this medical device.

Then please leave your details by clicking on the Aisys cs2 Support text below.

The LeQuest team will be in contact with you as soon as possible.

Aisys cs2 Support 

2020-03-16 17_13_40-CT-JS overview

Do you want to contribute to our mission?

Funded by leading investors who believe in our vision, we continue to grow fast. We currently work with the biggest medical device manufacturers in the world, we have developed more than 80 simulation-based training modules and are active in over 15 global markets.

Do you want to help us continue to improve patient safety and make a difference for medical staff globally by helping them become more proficient and confident in the use of medical technology? Get in touch with us today!

About LeQuest

LeQuest creates interactive and customized e-trainings that empower healthcare professionals to use medical technology with confidence and competence. The company’s innovative approach to online training improves the overall implementation and use of medical devices while relieving their customers of regulatory pressures – so they can focus on what is important: their patients.